The goal of our study was to assess the predictive value of radiomics features assessed on pre-treatment multi-phasic gadoxetic acid-enhanced (EOB-)MRI for prediction of response of hepatocellular carcinoma to 90Yttrium radioembolization (RE). We found that radiomics features measured at baseline were predictive of response assessed at 6 weeks and 6-12 months after treatment. These results indicate value of radiomics for prediction of RE response, which needs to be validated in a larger study.
This abstract and the presentation materials are available to members only; a login is required.